Using Circulating Tumor Cells To Evaluate Chemotherapy Efficacy Leading To Improved Clinical Decision Making
Today most doctors rely on their personal evaluation or objective response criteria (OR) of a man to know when docetaxel chemotherapy has stopped working. The earlier this determination can be accurately made the quicker an [...]
Prostate Cancer Kills Black Men at Twice the Rate as White Men
African American men suffer from Prostate Cancer more than anyone, anywhere. If we want better treatments, then we've got to tell folks what it means to be a African American man diagnosed with Prostate Cancer. [...]
The Latest Information On The Role Of Metformin Therapy In The Treatment Of Prostate Cancer
There have been prior studies that have shown that the generic and inexpensive drug Metformin (used to treat diabetes) could be repurposed and used to decrease the risk of developing prostate cancer as well as [...]
Quality Control Of Xofigo – Confirming That Intravenous Radium-223 Actually Becomes Systemic and Doesn’t Leak At The Injection Site
Radium-223 dichloride (Xofigo) has been approved as an intravenous radiotherapy for men with castration-resistant prostate cancer (CRPC) who have multiple osseous (bone) metastases. Most often, it is used in men who have too many metastases [...]
Funding Time for the DOD Prostate Cancer Research Program – Help Us To Protect It
Malecare has been an active and early member of the Defense Health Research Consortium. The consortium currently consists of 47 different organizations, which educate and advocate for research Department of Defense funding for multiple different [...]
Updated Overall Survival Data from a Phase 3 Trial of Ipilimumab vs. Placebo in Men Post Chemotherapy Receiving Radiation Therapy – Still Needs Time
Presented in a poster at the recent European Society of Medical Oncologist (ESMO) there was a data update of the phase 3 clinical trial (CA184-043) which evaluated overall survival (OS) in men having radiotherapy (RT) [...]